Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.63 is 74% above its 5-year average of -2.42, near the high end of its 5-year range (-5.44–0.10).
63.64% below its 12-month average of -0.39.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.19.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 8 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:25:23.183Z. Historical observations retain their original dates. Historical series through 2026-03-31.
EARNINGS PER SHARE (EPS)
-0.63
EARNINGS PER SHARE (EPS) AVG TTM
-0.39
EARNINGS PER SHARE (EPS) AVG 3Y
-1.45
EARNINGS PER SHARE (EPS) AVG 5Y
-2.42
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-63.64%
CURRENT VS 3Y AVG
+56.55%
CURRENT VS 5Y AVG
+73.91%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$2.06B
Earnings Per Share (EPS)
-1.50
TTM Avg
0.42
3Y Avg
-0.42
5Y Avg
-0.63
Market Cap
$2.05B
Earnings Per Share (EPS)
4.62
TTM Avg
3.38
3Y Avg
1.11
5Y Avg
0.12
Market Cap
$2.11B
Earnings Per Share (EPS)
5.70
TTM Avg
4.76
3Y Avg
4.08
5Y Avg
3.55
Market Cap
$2.02B
Earnings Per Share (EPS)
-2.54
TTM Avg
-3.71
3Y Avg
-3.97
5Y Avg
-3.29
Market Cap
$2.02B
Earnings Per Share (EPS)
2.29
TTM Avg
1.09
3Y Avg
0.22
5Y Avg
-0.23
Market Cap
$2.01B
Earnings Per Share (EPS)
-0.93
TTM Avg
-7.24
3Y Avg
-4.12
5Y Avg
-3.06
Market Cap
$2.00B
Earnings Per Share (EPS)
-0.68
TTM Avg
-0.29
3Y Avg
-0.44
5Y Avg
-0.50
Market Cap
$1.97B
Earnings Per Share (EPS)
-2.76
TTM Avg
-2.15
3Y Avg
-1.51
5Y Avg
-0.43
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alvotech (ALVO) | $2.07B | -0.63 | -0.39 | -1.45 | -2.42 |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.06B | -1.50 | 0.42 | -0.42 | -0.63 |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.05B | 4.62 | 3.38 | 1.11 | 0.12 |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 5.70 | 4.76 | 4.08 | 3.55 |
| Immunome, Inc. (IMNM)vs › | $2.02B | -2.54 | -3.71 | -3.97 | -3.29 |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 2.29 | 1.09 | 0.22 | -0.23 |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | -0.93 | -7.24 | -4.12 | -3.06 |
| AxoGen, Inc. (AXGN)vs › | $2.00B | -0.68 | -0.29 | -0.44 | -0.50 |
| Azenta, Inc. (AZTA)vs › | $1.97B | -2.76 | -2.15 | -1.51 | -0.43 |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.17B | -4.36 | -3.17 | -2.92 | -2.56 |
Trailing EPS (TTM)
$-0.63
Forward EPS (Est.)
$-0.01
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 0.10 |
| 2024-12-31 | -0.87 |
| 2023-12-31 | -2.43 |
| 2022-12-31 | -2.60 |
| 2021-12-31 | -3.25 |
| 2020-12-31 | -5.44 |
| 2019-12-31 | -0.86 |
